Wu et al. showed that diosmetin functioned as a suppressor of glioma growth, proliferation and migration in vivo and in vitro, probably for its inhibition of the TGF-β signaling pathway in glioma cells [102]. This evidence concerns the gene TGFB1 and glioma.